Background Eosinophilic annular erythema (EAE) has been proposed as a clinical entity to describe annular skin lesions associated with tissue eosinophilia. However, systematic investigations on the histopathology of EAE have not been performed, and useful histopathological findings for diagnosis of EAE remain unknown.
Introduction
As stated in the first report of eosinophilic annular erythema (EAE), the entity of EAE was proposed to describe annular skin lesions associated with tissue eosinophilia. 1 To date, 25 cases of EAE have been reported in the English literature. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] EAE is characterized by the appearance of persistent annular or figurate lesions, a chronic course with recurrent relapse and recalcitrance to various treatments. 11, 14 Typical EAE is histopathologically characterized by dense perivascular infiltrates with abundant eosinophils but without 'flame figures'. 15 Some EAE cases have been clinically documented as being accompanied by a dusky-toned area and pigmentation. 10, 14, 16 However, the frequency of discoloration has not been elucidated, and there have been no descriptions of histopathological examinations corresponding to the clinical pigmentation.
Furthermore, the pattern and depth of eosinophilic infiltration in EAE has not been well investigated, which leaves the clinicopathological distinction between EAE and Wells' syndrome (WS) unclear. To address these issues, we conducted a singlecentre, retrospective clinicopathological review of 10 cases of EAE. Our study demonstrates that most cases of EAE clinically show pigmentation and that the histological localization of eosinophils is limited to the dermis, without peripheral eosinophilia.
Materials and methods
A single-centre study of 10 patients diagnosed with EAE at Hokkaido University Hospital was performed. Their first visits were between 2011 and 2015. Based on the reports and studies in the past, we defined EAE as skin lesions that clinically show annular or figurate erythema and histopathologically exhibit abundant eosinophilic infiltration at least in the dermis. According to these criteria, we collected patients and retrospectively examined clinical features and histopathological findings. Data from the medical records included age, gender, past medical history, history of drug intake, disease duration, clinical features of lesions, symptoms, laboratory examination results (including whole blood cell count) and treatments and their responses. Histopathological findings including epidermal changes, basal melanosis, vacuolar changes, melanin incontinence, patterns of eosinophilic infiltration, flame figures, coat sleeve-like infiltration of lymphocytes around blood vessels, vasculitis and mucin deposition were reviewed.
Written consent for skin biopsy was obtained from each patient. All analyses in this study were performed in accordance with the ethical guidelines of Hokkaido University Hospital and the Declaration of Helsinki guidelines. The study was approved by the institutional review board of Hokkaido University Hospital (approval #015-0525; approval date: 17 June 2016).
Report of cases
We highlight two representative cases of EAE from our 10 cases.
Case #2: A 42-year-old Japanese woman presented with a 1-year history of a pruritic rash on the four extremities.
Treatment with systemic corticosteroid at the previous clinic brought temporary response. However, the rash recurred after the cessation of systemic corticosteroid. Physical examination revealed multiple annular erythema with peripheral infiltration on the extremities. Most of these lesions had brownish pigmentation (Fig. 1a) . A biopsy specimen from the periphery of erythema on the left thigh showed infiltration of inflammatory cells from the superficial to the middermis, including numerous eosinophils (Fig. 1b) . The pattern of infiltration by the eosinophils was interstitial rather than perivascular (Fig. 1c) . The epidermis presented basal melanosis and pigmentary incontinence (Fig. 1d ). There were few inflammatory cells, including eosinophils, in the subcutis. Topical application of 0.05% difluprednate ointment was successful, and the rash had disappeared by the time of 5-week follow-up. However, the erythema relapsed and treatment with topical corticosteroid was restarted. The rash finally resolved 18 months after the first visit.
Case #8: A 31-year-old Japanese woman presented with a 2-month history of a pruritic eruption on the left lower leg. The eruption had gradually expanding before she visited our outpatient clinic. Examination revealed annular erythema with peripheral palpable infiltration and diffuse pigmentation on the left popliteal fossa and lower leg (Fig. 2a) . Skin biopsy revealed perivascular and interstitial infiltration of inflammatory cells from the superficial to the mid-dermis, including lymphocytes and eosinophils (Fig. 2b, c ). Inflammatory cells, including eosinophils, did not extend to the subcutaneous tissue. The epidermis presented basal melanosis and mild focal spongiosis. There were mild vacuolar changes and slight pigmentary incontinence (Fig. 2d ). Mucin deposition was seen through the dermis. These annular erythemas spontaneously regressed without treatment within 4 weeks, and no recurrence was noted.
Results
We present the clinical information of the patients in Table 1 . There were seven women and three men aged 27-82 years. Associated systemic disorders were recorded in seven patients: asthma in three of these patients and rheumatoid arthritis in two of these patients. Other items from the medical histories included cervical cancer, breast carcinoma, chronic gastritis, Hashimoto disease, hypertension and osteoporosis, in one patient for each. The duration of EAE from onset to first visit ranged from 2 weeks to several years. Itching was marked in all patients; however, tenderness of the lesion was not described. There was no history of preceding insect bite or contact dermatitis in any case. The descriptions and photographs of the lesions revealed that nine cases had pigmentation mainly at the centre of the lesions. The histopathological findings of the skin biopsy are shown in Table 2 . The skin biopsy specimens were taken from erythema in each case. Three specimens included flat, pigmented central areas with slight erythema. Basal melanosis was observed in nine cases, and melanin incontinence was noted in three cases. According to findings of flat pigmented central areas, basal melanosis was shown in all three specimens and pigment incontinence in one specimen. Vacuolar change was observed in five cases. Eosinophils infiltrated the superficial dermis in all cases and the deep dermis in seven cases. Infiltration of eosinophils into the subcutis was noted in only one case. The pattern of EAE: A clinicopathological study of 10 cases eosinophilic infiltration was a mixture of perivascular and interstitial in nine cases (Fig. 3a, b) and was exclusively perivascular in one case (Fig. 3c, d ) (case #4). Inflammatory infiltrates including lymphocytes and eosinophils with coat-sleeve distribution were seen in four cases. Mucin deposition was observed in three cases. Flame figures and vasculitis were not seen. Elevated blood eosinophilia (>500/lL) was observed in only one of the 10 cases. The patient was associated with asthma and eosinophilic granulomatosis with polyangiitis and showed marked blood eosinophilia of up to 2.3 9 10 3 /lL (case #10).
According to serologic tests, anti-BP180 antibodies, anti-SS-A antibodies and anti-SS-B antibodies were negative in all 4, seven and six patients tested for them, respectively. As for treatments, four patients were treated with systemic corticosteroid (prednisolone 20-40 mg/day), four patients with topical corticosteroid and one patient with topical tacrolimus. The one remaining patient spontaneously resolved without treatment. Five of the nine patients showed a favourable course with no recurrence after cessation of the intervention. The mean duration of these five patients from the start of initial treatment to significant response was 3.8 weeks. Three of these five patients were treated with systemic corticosteroid (the mean duration to significant response was 2.0 weeks) and two others with topical corticosteroids (6.5 weeks). In contrast, one of four patients treated with systemic corticosteroid and three of five patients treated with topical corticosteroid relapsed. For the one patient whose initial treatment with topical corticosteroid was ineffective, the treatment was changed to topical tacrolimus with immediate effect and no relapse (case #4). The two remaining refractory patients treated with topical corticosteroid finally resolved with one or two repetitions of the same therapies. However, a male patient who was initially treated with systemic prednisolone at 40 mg/day showed a persistent course of the disease with remission and exacerbation (case #6). No cases were treated with hydroxychloroquine or other antimalarials.
Discussion
This study has elucidated the following. (i) Most cases clinically exhibited pigmentation that histopathologically resulted not from melanin incontinence but from basal melanosis. (ii) Prominent eosinophilic infiltration was observed in the dermis, whereas eosinophils were scarce in the subcutis and peripheral blood. Flame figures were not shown in any of the cases. (iii) EAE tends to respond more rapidly and relapse less frequently with systemic corticosteroid therapy than topical corticosteroid. (iv) EAE tends to affect women more often than men.
Even though some case reports of EAE have noted a dusky tone or pigmentation, 10, 11, 14 our study clearly demonstrates for the first time that EAE is clinically characterized by central pigmentation. As several previous EAE cases noted the histopathological finding of vacuolar change, 12, 16 we expected melanin incontinence would be a predominant finding corresponding to clinical pigmentation. However, our study unexpectedly demonstrated that basal melanosis (9 of 10) was observed more frequently than melanin incontinence (3 of 10), and vacuolar change was found in only 30% of EAE cases. Therefore, basal melanosis is considered to contribute mainly to clinical pigmentation. As melanocytes were not increased in our study, some factors may exist to activate melanogenesis of melanocytes in the pathophysiology of EAE. Melanocytes express IL-5 at a low level, 17 and it is possible that IL-5, which attracts eosinophils in the dermis, also acts on melanocytes. On the other hand, it can be also considered that melanogenesis of normal human melanocytes is inhibited by IL-4, which is produced by eosinophils (Fig. 4) . 18 Further studies are needed to clarify the relationship between melanocytes and eosinophilic infiltration.
In previous reports and studies of EAE, elevated levels of blood eosinophils tended to be found in cases without underlying disease. 11 However, except for two cases associated with underlying diseases, our cases showed no blood eosinophilia, despite there being active skin lesions. As for histological eosinophilic infiltration, El-Khawalany et al. 11 reported that the dermal eosinophils extended into the subcutis in well-developed and long-standing lesions. Conversely, most cases of EAE in the literature did not show abundant eosinophilic infiltration into the subcutis. [1] [2] [3] [4] 8, [12] [13] [14] [15] [16] In our study, eosinophilic infiltration into the subcutaneous tissue was noted in only one in 10 cases. Some previous reports of EAE described the presence of flame figures, [9] [10] [11] 14 Although the predominant opinion is that EAE represents a variant of WS with an annular or figurate clinical appearance, 11, 14 the relationship between EAE and WS remains a matter to be discussed further. As WS is usually accompanied by blood eosinophilia, 19 the absence of blood eosinophilia can be crucial in distinguishing EAE from WS. Furthermore in WS, the inflammatory cells, including eosinophils, often involve the subcutis as well as the dermis, and flame figures can be found as characteristic features. 20 The localization of eosinophils to the dermis and the absence of flame figures suggest EAE rather than WS (Fig. 4) . In previous reports, EAE patients frequently showed prolonged courses, resistance to various treatments and high relapse rates. 11 Contrary to these facts, however, our study demonstrated that three of four cases treated with systemic corticosteroids resolved without recurrence. In addition, although recurrence was observed in three out of five cases initially treated with topical corticosteroids, all four cases of EAE treated with long-term topical corticosteroids finally resolved in our study. As in one previous report, 12 The male:female ratio of EAE was 3 : 7 in our cases and 13 : 15 in previous reports; there is a slight predominance in females. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The reason is yet to be elucidated, but three EAE female cases had a history of autoimmune disorders in our study. Also, histories of thyroiditis were found in previous female cases. 1, 3 Therefore, autoimmunity might be involved in the pathophysiology and female predominance of EAE.
Conclusion
EAE should be included as a differential diagnosis of annular figurate erythema, in addition to major skin disorders such as erythema annulare centrifugum, drug eruption, subacute cutaneous lupus erythematosus and bullous pemphigoid, even if there is no blood eosinophilia. Skin biopsy is needed to confirm the diagnosis of EAE. Eosinophilic infiltration confined to the dermis and basal melanosis suggest the diagnosis of EAE. Systemic corticosteroid is recommended for EAE if treatment with topical corticosteroid is ineffective.
